1. Home
  2. VRNA vs OII Comparison

VRNA vs OII Comparison

Compare VRNA & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • OII
  • Stock Information
  • Founded
  • VRNA 2005
  • OII 1964
  • Country
  • VRNA United Kingdom
  • OII United States
  • Employees
  • VRNA N/A
  • OII N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • OII Oilfield Services/Equipment
  • Sector
  • VRNA Health Care
  • OII Energy
  • Exchange
  • VRNA Nasdaq
  • OII Nasdaq
  • Market Cap
  • VRNA 3.2B
  • OII 2.6B
  • IPO Year
  • VRNA 2017
  • OII N/A
  • Fundamental
  • Price
  • VRNA $43.06
  • OII $25.57
  • Analyst Decision
  • VRNA Strong Buy
  • OII Buy
  • Analyst Count
  • VRNA 6
  • OII 4
  • Target Price
  • VRNA $43.83
  • OII $27.00
  • AVG Volume (30 Days)
  • VRNA 1.0M
  • OII 726.9K
  • Earning Date
  • VRNA 11-04-2024
  • OII 10-23-2024
  • Dividend Yield
  • VRNA N/A
  • OII N/A
  • EPS Growth
  • VRNA N/A
  • OII 76.07
  • EPS
  • VRNA N/A
  • OII 1.32
  • Revenue
  • VRNA $5,624,000.00
  • OII $2,602,340,000.00
  • Revenue This Year
  • VRNA N/A
  • OII $9.75
  • Revenue Next Year
  • VRNA $644.06
  • OII $7.25
  • P/E Ratio
  • VRNA N/A
  • OII $19.05
  • Revenue Growth
  • VRNA 1127.95
  • OII 12.84
  • 52 Week Low
  • VRNA $11.39
  • OII $18.95
  • 52 Week High
  • VRNA $43.73
  • OII $30.98
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 61.99
  • OII 35.71
  • Support Level
  • VRNA $38.77
  • OII $26.66
  • Resistance Level
  • VRNA $43.73
  • OII $27.73
  • Average True Range (ATR)
  • VRNA 1.41
  • OII 0.97
  • MACD
  • VRNA 0.07
  • OII -0.52
  • Stochastic Oscillator
  • VRNA 60.80
  • OII 9.79

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About OII Oceaneering International Inc.

Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.

Share on Social Networks: